Aandelen in “Testlaboratoria”

Aandeel Datum Koers Evolutie
vlag Physiomics 12/09 0,445 GBX
+2,30% 		+2,30%
vlag Proteome Sciences plc 12/09 3,460 GBX
+4,53% 		+4,53%
vlag PureTech Health Plc 12/09 113,800 GBX
-0,35% 		-0,35%
vlag PureTech Health Plc 12/09 16,080 USD
-1,41% 		-1,41%

Nieuws over “Testlaboratoria”

9/09 · CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics · Persbericht

9/09 · CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics · Persbericht

2/09 · Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. · Persbericht

27/08 · 10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference · Persbericht

19/08 · 10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis · Persbericht

7/08 · 10x Genomics Reports Second Quarter 2025 Financial Results · Persbericht

7/08 · 10x Genomics to Acquire Scale Biosciences · Persbericht

5/08 · WENDEL: Successful issue of €500 million 8-year bond bearing interest at 3.75% · Persbericht

4/08 · WENDEL: Investor conference calls ahead of the launch of a potential €500 million 8-year bond issue · Persbericht

1/08 · Mee met de markt:'Tarief deadline' · Bolero.be

In de aanloop naar “tariefdag”, zoals 1 augustus 2025 in de analen zal gaan, konden beleggers niet ontsnappen aan de zwaartekracht. Met ietwat daver op het lijf was en is de vraag welke tarieven er nu effectief zullen geheven...

30/07 · WENDEL: 2025 Half-Year Results · Persbericht

17/07 · 10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery · Persbericht

10/07 · 10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025 · Persbericht

21/06 · AKOYA BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA · Persbericht

Mijn selecties